From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain

Journal of Neural Transmission

Volumn 113, Issue 11, 2006, Pages 1671-1677

  Riederer, P ^a   Hoyer, S ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Advanced glycation end products; Alzheimer disease; Brain; Cell damage; Glutamate; Memantine; NMDA receptor

Indexed keywords

ACETYLCHOLINE; CHOLINESTERASE INHIBITOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; MEMANTINE; NEUROTRANSMITTER;

AGING; ALZHEIMER DISEASE; BRAIN REGION; CELL DAMAGE; COGNITION; DRUG MECHANISM; GLUCOSE METABOLISM; GLYCATION; HUMAN; LEARNING; MAMMAL; MEMORY; MENTAL CAPACITY; NERVE DEGENERATION; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW;

ACETYLCHOLINE; ALZHEIMER DISEASE; ANIMALS; BRAIN; GLUTAMIC ACID; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; SYNAPTIC TRANSMISSION;

EID: 33750444913     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-006-0591-6     Document Type: Review

References (103)

1. CA Barnes W Danysz CG Parsons 1996 Effects of the uncompetitive NMDA receptor antagonist memantine on hippocampal long-term potentiation, short-term exploratory modulation and spatial memory in awake, freely moving rats Eur J Neurosci 8 565 571
2. ZI Bashir ZA Bortolotto CH Davies N Berretta AJ Irving AJ Seal JM Henley DE Jane JC Watkins Collingridge 1993 Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors Nature 363 347 350
3. +H) glutamate receptor binding in aged rats Brain Res 223 195 198
4. G Benzi O Pastoris RF Villa AM Giuffrida 1984 Effect of aging on cerebral cortex energy metabolism in hypoglycemia and posthypoglycemic recovery Neurobiol Aging 5 205 212
5. 3H] MK-8a binding to human hippocampal NMDH receptors NeuroReport 5 1237 1240
6. A Bierhaus T Illmer M Kasper T Lüther P Quehenberger H Tritschler P Wahl R Ziegler M Müller PP Nawroth 1997 Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE Circulation 96 2262 2271
7. V Bigl NJ Woolf LL Butcher 1982 Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital and cingulate cortices: a combined fluorescent tracer and acetylcholinesterase analysis Brain Res Bull 8 727 749
8. TVP Bliss GL Collingridge 1993 A synaptic model of memory: long-term potentation in the hippocmapus Nature 361 31 39
9. J Brett AM Schmidt SD Yan YS Zou E Weidman D Pinsky R Nowygrod M Neeper C Przysiecki A Shaw 1993 Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues Am J Pathol 143 1699 1712
10. GL Collingridge 1987 The role of NMDA receptors in learning and memory Nature 330 604 605
11. 1 hippocampal neurons Science 240 649 653
12. W Danysz CG Parsons HJ Möbius A Stöffler G Quack 2000 Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease - a mechanism of action Neurotox Res 2 85 97
13. W Danysz JT Wroblewski E Costa 1988 Learning impairment in rats by N-methyl-D-aspartate receptor antagonists Neuropharmacolgoy 27 653 656
14. P Davidsson K Blennow N Andreasen B Eriksson L Minton C Hesse 2001 Differential increase in cerebrospinal fluid - acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease Neurosci Lett 300 157 160
15. SW Davies GJ [tmp] McBean PJ Roberts 1984 A glutamatergic innervation of the nucleus basalis/substantia innominata Neurosci Lett 45 105 110
16. W Deuther-Conrad C Loske R Schinzel R Dringen P Riederer G Münch 2001 Advanced glycation endproducts change glutathione redox status in SH-SY5Y human neuroblastoma cells by a hydrogen peroxide dependent mechanism Neurosci Lett 12 312 1 29 32
17. DA Drachman D Noffsinger BJ Jahakian S Kurdziel P Flemming 1980 Aging, memory and the cholinergic system: a study of dichotic listening Neurobiol Aging 1 39 43
18. S Dukic-Stefanovic R Schinzel P Riederer G Münch 2001 Ages in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs Biogerontology 2 19 34
19. MR Farlow PN Tariot GT Grossbery I Gergel S Graham J Jin 2003 Memantine/donepezil dualtherapy is superior to placebo/donepezil therapy for treatment of moderate to severe Alzheimer's disease Neurology 60 A412
20. AA Farooqui LA Horrocks 1991 Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders Brain Res Rev 16 171 191
21. PT Francis NR Simus AW Procter DM Bowen 1993 Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives J Neurochem 60 1589 1604
22. WY Freed RJ Wyatt 1981 Impairment of instrumental learning in rats by glutamic acid diethyl ester Pharmacol Biochem Behav 14 223 226
23. GB Freeman GE Gibson 1987 Selective alteration of mouse brain neurotransmitter release with age Neurobiol Aging 8 147 152
24. U Frey W Retz P Riederer M Rösler 2000 Neue Aspekte in der antidementiven Pharmakotherapie der Alzheimer-Erkrankung Akt Neurol 27 305 317
25. GP Gasic U Heinemann 1991 Receptors coupled to ionic channels: the glutamate receptor family Curr Opin Neurobiol 1 20 26
26. EL Gibbs WG Lennox LF Nims FA Gibbs 1942 Arterial and cerebral venous blood: arterial-venous differences in man J Biol Chem 114 325 332
27. GE Gibson JP Blass 1976 Impaired synthesis of acetylcholine in brain accompanying mild hypoxia and hypoglycemia J Neurochem 27 37 42
28. GE Gibson C Peterson 1981 Aging decreases oxidative metabolism and the release and synthesis of acetylcholine J Neurochem 37 978 984
29. PE Gold SF Zornetzer 1983 The mnemon and juices: neuromodulation of memory processes Behav Neural Biol 38 151 189
30. U Gottstein A Bernsmeier I Sedlmeyer 1963 Der Kohlenhydratstoffwechsel des menschlichen Gehirns. I. Untersuchungen mit substratspezifischen enzymatischen Methoden bei normaler Hirndurchblutung Klin Wschr 41 943 948
31. JT Greenamyre 1986 The role of glutamate in neurotransmission and in neurological disease Arch Neurol 43 1057 1062
32. JT Greenamyre HB Young 1989 Excitatory amino acids and Alzheimer's disease Neurobiol Aging 10 593 602
33. W Gsell I Strein U Krause P Riederer 1997 Neurochemical abnormalities in Alzheimer's disease and Parkinson's disease - a comparative review J Neural Transm Suppl 51 45 49 Review
34. W Gsell G Jungkunz P Riederer 2004 Functional neurochemistry of Alzheimer's disease Curr Pharmaceut Design 10 265 293
35. JA Hardy RF Cowburn 1987 Glutamate neurotoxicity and Alzheimer's disease Trends Neurosci 10 406
36. CR Harrington CA Colaco 1994 Alzheimer's disease. A glycation connection Nature 370 247 248
37. S Hoyer 1970 Der Aminosäurenstoffwechsel des normalen menschlichen Gehirns Klin Wschr 48 1239 1243
38. S Hoyer 1985 The effect of age on glucose and energy metabolism in brain cortex of rats Arch Gerontol Geriatr 4 193 203
39. S Hoyer 1990 Brain glucose and energy metabolism during normal aging Aging 2 245 258
40. S Hoyer 1992 Oxidative energy metabolism in Alzheimer brain. Studies in early-onset and late-onset cases Mol Chem Neuropathol 16 207 224
41. S Hoyer K Betz 1998 Abnormalities in glucose and energy metabolism are more severe in the hippocampus than in the cerebral cortex in postischemic recovery in aged rats Neurosci Lett 94 167 172
42. S Hoyer C Krier 1986 Ischemia and the aging brain. Studies on glucose and energy metabolism in rat cerebral cortex Neurobiol Aging 7 23 29
43. S Hoyer P Riederer 2003 Pathomechanismen und hypothesengeleitete Therapieoptionen bei der Spätform der Alzheimer-Krankheit Fortschr Neurol Psychiatr 71 16 26
44. Jacob CP, Hoffmann M, Bartl J, Neuen-Jacob E, Koutsilieri E, Zander N, Ravid R, Roggendorf W, Riederer P, Grünblatt E (2006) Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease. J Alzheimer's Dis (submitted)
45. CE Jahr CF Stevens 1987 Glutamate activates multiple single channel conductances in hippocampal neurons Nature 325 522 525
46. T Kimura J Takamatzu K Ideda A Kondo T Miyakawa S Horiuchi 1996 Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons Neurosci Lett 208 53 56
47. J Kornhuber J Bormann W Retz M Hübers P Riederer 1989 Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex Eur J Pharmacol 166 589 590
48. J Kornhuber J Bormann M Hübers K Rusche P Riederer 1991 Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel a human postmortem brain study Eur J Pharmacol - Mol Pharmacol Sect 206 297 300
49. HM Lander JM Tauras JS Ogiste O Hori RA Moss AM Schmidt 1997 Activation of the receptor for advanced glycation end products triggers a p21 (ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress J Biol Chem 272 17810 17814
50. MD Ledesma P Bonay J Avila 1995 Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain J Neurochem 65 1658 1664
51. MD Ledesma P Bonay C Colaco J Avila 1994 Analysis of microtubule- associated protein tau glycation in paired helical filaments J Biol Chem 269 21614 21619
52. JJ Li M Surini S Catsicas E Kawashima C Bouras 1995 Age-dependent accumulation of advanced glycation end products in human neurons Neurobiol Aging 16 69 76
53. AS Lippa DJ Critchett F Ehlert HI Yamamura SJ Enna RT Bartus 1981 Age-related alterations in neurotransmitter receptors: an electrophysiological and biochemical analysis Neurobiol Aging 2 3 8
54. D Lodge W Danysz CG Parsons 2002 Ionotropic glutamate receptors as therapeutic targets Graham Publ. Johnson City, Tennessee
55. G Lynch M Baudry 1984 The biochemistry of memory: a new and specific hypothesis Science 224 1057 1063
56. 3H)-TCP binding and NMDA receptors Eur J Pharmacol 123 173 174
57. K Maurer S Hoyer 2006 Alois Alzheimer revisited: differences in origin of the disease carrying his name J Neural Transm 113 1645 1658
58. 3H) glutamate-binding sites in rat brain J Neurosci 5 2909 2919
59. VM Monnier A Cerami 1982 Nonenzymatic browning in vivo: possible process for aging of long-lived proteins Science 211 491 493
60. VM Monnier DR Sell RH Nagaraj S Miyata 1991 Mechanisms of protection against damage mediated by the Maillard reaction in aging Gerontology 37 152 165
61. RGM Morris 1989 Synaptic plasticity and learning: selective impairment of learning in rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5 J Neurosci 9 3040 3057
62. RGM Morris E Anderson GS Lynch M Baudry 1986 Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5 Nature 319 774 776
63. WE Müller E Mutschler P Riederer 1995 Noncompetitive NMDA receptor antagonist with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer's dementia Pharmacopsychiatry 28 113 124
64. G Münch Y Taneli E Schraven U Schindler R Schinzel D Palm P Riederer 1994 The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation J Neural Transm P-D Sect 8 193 208
65. G Münch A Simm KL Double P Riederer 1996 Commentary: oxidative stress and advanced glycation end products - parts of a vicious circle of neurodegeneration? Alzheimers Dis Rev 1 71 74
66. G Münch S Mayer J Michaelis AR Hipkiss R Schinzel P Riederer AM Cunningham 1997a Influence of advanced glycosylation end products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptide Biochem Biophys Acta 1360 17 29
67. G Münch J Thome P Foley R Schinzel P Riederer 1997b Advanced glycation end products in ageing and Alzheimer's disease Brain Res Rev 23 134 143
68. G Münch R Schinzel C Loske A Wong N Durany JJ Li H Vlassara MA Smith G Perry P Riederer 1998 Alzheimer's disease-synergistic effects of glucose deficit, oxidative stress and advanced glycation end-products J Neural Transm 105 439 461
69. G Münch J Gasic-Milenkovic S Dukic-Stefanovic B Kuhla K Heinrich P Riederer HJ Huttunen H Founds G Sajithlal 2003 Microglial activation induces cell death, inhibits neurite outgrowth and causes neurite retraction of differentiated neuroblastoma cells Exp Brain Res 150 1 8
70. CJ Mullarkey D Edelstein M Brownlee 1990 Free radical generation by early glycation products: a mechanisms for accelerated atherogenesis in diabetes Biochem Biophys Res Commun 173 932 939
71. A Novelli JA Reilly PG Lysko RG Henneberry 1988 Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced Brain Res 451 205 212
72. A Ott MMB Breteler F van Harskamp JJ Clauss TJM van der Cammen DE Grobbee A Hofmann 1995 Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study BMJ 310 970 973
73. F Pedata J Slavikova A Kotas G Pepeu 1983 Acetylcholine release form rat cortical slices during postnatal development and aging Neurobiol Aging 4 31 35
74. JB Penney WF Maragos JT Greenamyre DL Debowey Z Hollingsworth AB Young 1990 Excitatory amino acid binding sites in the hippocampal region of Alzheimer's disease and other dementias Neurol Neurosurg Psychiatry 53 314 320
75. AP Periclou D Ventura T Sherman N Rao WT Abramowitz 2004 Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil Ann Pharmacother 38 1389 1394
76. AW Procter AM Palmer PT Francis SL Lowe D Neary E Murphy R Doshi DM Bowen 1988 Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease J Neurochem 50 790 802
77. B Reisberg R Doody A Stöffler F Schmitt S Ferries HJ Möbius 2003 Memantine in moderate-to-severe Alzheimer's disease N Engl J Med 348 1333 1341
78. W Retz J Kornhuber P Riederer 1996 Neurotransmission and the ontogeny of human brain J Neural Transm 103 403 419
79. P Riederer S Hoyer 2005 Störungen der Neurotransmission bei Demenzen CW Wallesch H Förstl Demenzen Thieme Stuttgart 27 43
80. MA Rogawski GL Wenk 2003 The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease CNS Drug Rev 9 275 308
81. W Sacks 1957 Cerebral metabolism of isotopic glucose in normal human subjects J Appl Physiol 10 37 44
82. W Sacks 1965 Cerebral metabolism of double labeled glucose in humans in vivo J Appl Physiol 20 117 130
83. R Schliebs T Arendt 2006 The significance of the cholinergic system in the brain during aging and in Alzheimer's disease J Neural Transm 113 1625 1644
84. AM Schmidt O Hori R Cao SD Yan J Brett JL Wautier S Ogaea K Kuwabara M Matsumoto D Stern 1996 RAGE, a novel cellular receptor for advanced glycation end products Diabetes 40 77 80
85. H Simm G Münch F Seif O Schenk A Heidland H Richter S Vamvakas R Schinzel 1997 Advanced glycation end products activate the MAP kinase pathway in the tubulus cell line LLC-PK1 FEBS Lett 410 481 484
86. NR Sims DM Bowen SJ Allen CCT Smith D Neary DJ Thomas AN Davison 1983 Presynaptic cholinergic dysfunction in patients with dementia J Neurochem 40 503 509
87. MA Smith LM Sayre VM Monnier G Perry 1995 Radical AGEing in Alzheimer's disease Trends Neurosci 18 172 176
88. MA Smith S Taneda PL Richey S Miyata SD Yan D Stern LM Sayre VM Monnier G Perry 1994 Advanced Maillard reaction end products are associated with Alzheimer disease pathology Proc Natl Acad Sci USA 91 5710 5714
89. J Stecher WE Müller S Hoyer 1997 Learning abilities depend on NMDA-receptor density in hippocampus in adult rats J Neural Transm 104 281 289
90. T Tsumoto 1990 Excitatory amino acid transmitters and their receptors in neural circuits of the cerebral neocortex Neurosci Res 9 79 102
91. J Ulas LC Brünner JW Geddes W Choe CW Cotman 1992 N-methyl-D-aspartate receptor complex in the hippocampus of elderly, normal individuals and those with Alzheimer's disease Neurosci 49 45 61
92. MP Vitek K Bhattacharya JM Glendening E Stoper H Vlassara R Bucala K Manogue A Cerami 1994 Advanced glycation end products contribute to amyloidosis in Alzheimer disease Proc Natl Acad Sci USA 91 4766 4770
93. H Vlassara M Brownlee A Cerami 1985 High-affinity receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules Proc Natl Acad Sci USA 82 5588 5592
94. H Vlassara R Bucala L Striker 1994 Biology of disease. Pathogenetic effects of advanced glycation: biochemical, biologic and clinical implications for diabetes and aging Lab Invest 70 138 151
95. GL Wenk CM Grey DK Ingram EL Spangler DS Olton 1989 Retention of maze performance inversely correlates with NMDA receptor number in hippocampus and frontal neocortex in rat Behav Neurosci 103 688 690
96. GL Wenk G Quack JH Moebius W Danysz 2000 No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use Life Sci 66 1079 1083
97. T Wieloch 1986 Endogenous excitotoxins as possible mediators of ischemic and hypoglycemic brain damage Adv Exp Med Biol 203 127 138
98. A Wong R Schinzel H Weisinger P Riederer G Münch 2001 Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia Eur J Neurosci 14 1961 1967
99. KL Wong GM Tyce 1983 Glucose and amino acid metabolism in rat brain during sustained hypoglycemia Neurochem Res 8 401 415
100. SD Yan X Chen J Fu M Chen JH Zhu A Roher T Slattery L Zhao M Nagashima J Morser A Migheli P Nawroth D Stern AM Schmidt 1996 RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease Nature 382 685 691
101. AB Young GB Fagg 1990 Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches Trends Pharmacol Sci 11 126 133
102. W Zajaczkowski G Quack W Danysz 1996 Infusion of (+)-MK-801 and memantine-contrasting effects on radial maze learning in rats with entorhinal cortex lesion Eur J Pharmacol 296 239 246
103. L Zanotto U Heinemann 1983 Aspartate and glutamate induced reactions on extracellular free calcium and sodium concentration in area CA1 of "in vitro" hippocampal slices of rats Neurosci Lett 35 79 84